Award details

Development of hybrid AAV/HSV vectors for gene delivery to skeletal muscle: applications in the treatment of MPS disease

ReferenceGTH12543
Principal Investigator / Supervisor Dr R Coffin
Co-Investigators /
Co-Supervisors
Professor Adrian Thrasher, Professor Bryan Winchester
Institution University College London
DepartmentImmunology and Molecular Pathology
Funding typeResearch
Value (£) 172,736
StatusCompleted
TypeResearch Grant
Start date 01/04/2000
End date 01/04/2003
Duration36 months

Abstract

The study aims to provide improved technology for the production of adeno- associated virus (AAV) vectors using herpes simplex virus (HSV) rather than the more usual adenovirus for virus growth. It is aimed to develop a transfection-free AAV production method using hybrid AAV/HSV constructs and viruses which, unlike current systems, will allow effective scale-up of AAV production. AAV is highly promising for gene delivery to muscle. The project aims to test AAV vectors for treatment of Hurler's disease (an MPS disease) in a knockout mouse model following gene delivery to skeletal muscle. Such an approach is promising as the deficient enzyme in Hurler's disease is naturally secreted from expressing cells, and moreover can be re-absorbed elsewhere to hopefully provide a therapeutic effect.

Summary

unavailable
Committee Closed Committee - Genes & Developmental Biology (GDB)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative Gene Technologies Underpinning Healthcare (GTH) [1999]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file